Literature DB >> 26104559

Mammalian Endogenous Retroviruses.

Dixie L Mager1, Jonathan P Stoye2.   

Abstract

Over 40% of mammalian genomes comprise the products of reverse transcription. Among such retrotransposed sequences are those characterized by the presence of long terminal repeats (LTRs), including the endogenous retroviruses (ERVs), which are inherited genetic elements closely resembling the proviruses formed following exogenous retrovirus infection. Sequences derived from ERVs make up at least 8 to 10% of the human and mouse genomes and range from ancient sequences that predate mammalian divergence to elements that are currently still active. In this chapter we describe the discovery, classification and origins of ERVs in mammals and consider cellular mechanisms that have evolved to control their expression. We also discuss the negative effects of ERVs as agents of genetic disease and cancer and review examples of ERV protein domestication to serve host functions, as in placental development. Finally, we address growing evidence that the gene regulatory potential of ERV LTRs has been exploited multiple times during evolution to regulate genes and gene networks. Thus, although recently endogenized retroviral elements are often pathogenic, those that survive the forces of negative selection become neutral components of the host genome or can be harnessed to serve beneficial roles.

Entities:  

Mesh:

Year:  2015        PMID: 26104559     DOI: 10.1128/microbiolspec.MDNA3-0009-2014

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  72 in total

Review 1.  Viral vectors for therapy of neurologic diseases.

Authors:  Sourav R Choudhury; Eloise Hudry; Casey A Maguire; Miguel Sena-Esteves; Xandra O Breakefield; Paola Grandi
Journal:  Neuropharmacology       Date:  2016-02-21       Impact factor: 5.250

2.  HEMO, an ancestral endogenous retroviral envelope protein shed in the blood of pregnant women and expressed in pluripotent stem cells and tumors.

Authors:  Odile Heidmann; Anthony Béguin; Janio Paternina; Raphaël Berthier; Marc Deloger; Olivia Bawa; Thierry Heidmann
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

3.  Capture of a Hyena-Specific Retroviral Envelope Gene with Placental Expression Associated in Evolution with the Unique Emergence among Carnivorans of Hemochorial Placentation in Hyaenidae.

Authors:  Mathis Funk; Guillaume Cornelis; Cécile Vernochet; Odile Heidmann; Anne Dupressoir; Alan Conley; Stephen Glickman; Thierry Heidmann
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

Review 4.  Immune responses to endogenous retroelements: taking the bad with the good.

Authors:  George Kassiotis; Jonathan P Stoye
Journal:  Nat Rev Immunol       Date:  2016-04       Impact factor: 53.106

Review 5.  LINE-1 retrotransposons in healthy and diseased human brain.

Authors:  Nicole A Suarez; Angela Macia; Alysson R Muotri
Journal:  Dev Neurobiol       Date:  2017-12-29       Impact factor: 3.964

6.  An RB-EZH2 Complex Mediates Silencing of Repetitive DNA Sequences.

Authors:  Charles A Ishak; Aren E Marshall; Daniel T Passos; Carlee R White; Seung J Kim; Matthew J Cecchini; Sara Ferwati; William A MacDonald; Christopher J Howlett; Ian D Welch; Seth M Rubin; Mellissa R W Mann; Frederick A Dick
Journal:  Mol Cell       Date:  2016-11-23       Impact factor: 17.970

7.  Human APOBEC3G Prevents Emergence of Infectious Endogenous Retrovirus in Mice.

Authors:  Rebecca S Treger; Maria Tokuyama; Huiping Dong; Karen Salas-Briceno; Susan R Ross; Yong Kong; Akiko Iwasaki
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

8.  A Role for Retrotransposons in Chromothripsis.

Authors:  Dustin C Hancks
Journal:  Methods Mol Biol       Date:  2018

9.  Unexpected Discovery and Expression of Amphibian Class II Endogenous Retroviruses.

Authors:  Mingyue Chen; Xiaoxia Guo; Lei Zhang
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

Review 10.  Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.

Authors:  Elisa Orecchini; Loredana Frassinelli; Silvia Galardi; Silvia Anna Ciafrè; Alessandro Michienzi
Journal:  Chromosome Res       Date:  2018-02-02       Impact factor: 5.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.